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Abstract
Multiple genetic modifications in pigs can essentially benefit research on agriculture, human disease and xenotransplan-
tation. Most multi-transgenic pigs have been produced by complex and time-consuming breeding programs using multiple
single-transgenic pigs. This study explored the feasibility of producing multi-transgenic pigs using the viral 2A peptide in
the light of previous research indicating that it can be utilized for multi-gene transfer in gene therapy and somatic cell
reprogramming. A 2A peptide-based double-promoter expression vector that mediated the expression of four fluorescent
proteins was constructed and transfected into primary porcine fetal fibroblasts. Cell colonies (54.3%) formed under G418
selection co-expressed the four fluorescent proteins at uniformly high levels. The reconstructed embryos, which were
obtained by somatic cell nuclear transfer and confirmed to express the four fluorescent proteins evenly, were transplanted
into seven recipient gilts. Eleven piglets were delivered by two gilts, and seven of them co-expressed the four fluorescent
proteins at equivalently high levels in various tissues. The fluorescence intensities were directly observed at the nose, hoof
and tongue using goggles. The results suggest that the strategy of combining the 2A peptide and double promoters
efficiently mediates the co-expression of the four fluorescent proteins in pigs and is hence a promising methodology to
generate multi-transgenic pigs by a single nuclear transfer.
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Introduction
The genetic modification of swine can have a multitude of
agricultural and medical applications. In agriculture, modifications
in the swine genome could alter the pork composition and produce
healthier meat, create swine strains that are more resistant to
specific diseases, reduce the embryonic losses normally observed
during the first month of swine embryogenesis, and breed animals
that are more environmentally friendly [1–4]. In the medical field,
specific genetic modifications in swine may afford organs for pig-
to-human xenotransplantation, produce recombinant products for
biomedical or nutraceutical use, as well as generate models of
human diseases for medical research and drug development
[3,5,6].
However, in many situations, multiple genes are required to be
simultaneously modified in pigs to achieve a certain goal. For
instance, in agriculture, it might be necessary to produce pigs with
several favorable traits (e.g., low fat/muscle ratio, high disease
resistance, and enriched with special nutrients), hence requiring
multiple corresponding genes to be transferred into the pigs. In
medical research, the transfer of multiple foreign genes into pigs is
necessary for generating models of various human diseases, such as
Alzheimer’s disease and Parkinson’s disease, which are related to
multiple genes or factors [7,8]. Multi-gene transfer has also been
implicated in xenotransplantation research. Organs from multi-
transgenic pigs expressing two or three complement genes
involved in immunological rejection have exhibited prolonged
xenograft survival [9–13].
Most multi-transgenic pigs have been produced by complex and
time-consuming breeding programs that utilize different single-
transgenic pigs [13,14]. Sperm-mediated gene transfer (SMGT)
has been previously reported for multi-transgenic pig production
[15], but the prolonged expression of transgenes remains
controversial [16]. A possible method to generate multi-transgenic
pigs is by transfecting multiple plasmids (each containing one gene)
simultaneously into porcine fetal fibroblasts (PFFs), which are then
used for somatic cell nuclear transfer (SCNT). However, our
previous data (unpublished) showed that the efficiency of this
method was particularly low in both cell transfection and selection
as well as in proteins co-expression in cloned piglets. The internal
ribosomal entry site (IRES), which has been conventionally used
for polycistronic expression cassettes, may be another choice for
generation of multi-transgenic pigs. However, in vectors contain-
ing the IRES sequence, the gene placed downstream is often
expressed at a much lower level than the gene located upstream
[17,18].
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IRES for mediating polycistronic expression in gene therapy and
somatic cells reprogramming [19–22]. This peptide, which
originates from the picornaviruses, is approximately 19 amino
acids long and contains a conserved and functional motif D (V/
I) EXNPGP. It is also called a ‘‘self-cleaving’’ peptide or
protease site because it is able to ‘‘cleave’’ at its own C terminus
between the last two amino acids through ribosomal skipping
during protein translation. Briefly, a normal peptide bond
formation between the glycine and the proline is impaired at the
2A site, which causes the ribosome to skip and begin to translate
from the second codon, resulting in the expression of two
independent proteins from a single transcription event [23].
Considering the high ‘‘cleavage’’ efficiency at the 2A site, the 2A
peptide can be used to mediate multiple genes expression in a
polycistron. Previous studies have confirmed the feasibility of
using the 2A site for the expression of multiple transgenes
[24,25], and 2A-based polycistronic expression has gained great
success in generating induced pluripotent stem cells that require
four factors working together [20,21,26–28]. The 2A peptide has
also been shown to be more efficient in mediating multiple
transgenes expression than IRES. Chinnasamy et al. [29] have
reported that the expression of enhanced green fluorescent
proteins (EGFP) in an MGMT-2A-EGFP bicistronic vector is
approximately four times greater than that in an IRES-based
vector. And the size of 2A peptide coding sequence is much
smaller than that of IRES sequence. These unique properties of
the 2A peptide make it a promising tool for generating multi-
transgenic pigs.
In this study, a 2A peptide-based double-promoter expression
vector that mediated the expression of four fluorescent proteins,
namely, yellow fluorescent protein (ZsYellow1), enhanced cyan
fluorescent protein (ECFP), red fluorescent protein (tdTomato),
and EGFP was constructed to generate multi-transgenic pigs.
Transgenic piglets were obtained, and the expressions of the four
fluorescent proteins in these piglets were examined.
Methods
Ethics statement
The animal experiment was approved by the Department of
Science and Technology of Guangdong Province, with an
approval ID SYXK (Guangdong) 2005-0063, and complied with
the guidelines of the Animal Care Committee, Guangzhou
Institute of Biomedicine and Health, Chinese Academy of
Sciences.
Vector construction
The 2A sequence of the foot and mouth disease virus was
synthesized and inserted into the pBlueScript KS(-) vector (pBS-
2A). ZsYellow1, ECFP, tdTomato and EGFP, cDNAs were
amplified by PCR from pZsYellow1, pECFPN1, pCMV-tdTo-
mato, and pEGFPC1 (Clontech), respectively, and cloned into
pBS-2A to generate pBS-cDNA-2A vectors. The tdTomato-2A
and ZsYellow1-2A fragments were then cut off from the
corresponding vectors and inserted into pBS-EGFP-2A to
generate pBS-tdTomato-2A-EGFP-2A-ZsYellow1-2A.The tdTo-
mato-2A-EGFP-2A-ZsYellow1-2A construct was then ligated to
ECFP cDNA and inserted into a pCAG vector containing the
CAG promoter (a composite of chicken b-actin promoter and
cytomegalovirus early enhancer element) [30] to generate pCAG-
tdTomato-2A-EGFP-2A-ZsYellow1-2A-ECFP (pTGZC).
The EGFP and ECFP cDNAs were inserted into pBS-
tdTomato-2A and pBS-ZsYellow1-2A generating pBS-tdTo-
mato-2A-EGFP and pBS-ZsYellow1-2A-ECFP, respectively, to
construct a vector in which the expressions of the four fluorescent
genes were driven by two independent CAG promoters. The
tdTomato-2A-EGFP (TG) and ZsYellow1-2A-ECFP (ZC) con-
structs were then subcloned into the pCAG vector to generate
pCAG-TG and pCAG-ZC, respectively,followed by the insertion
of the CAG-ZC fragment into the pCAG-TG vector to generate
the 2A peptide-based double-promoter vector pZCpTG.
Primary cell isolation and culture
PFFs were prepared as previously described [5]. Briefly, A 35-
day-old fetus (landrace) without head, limbs, and internal organs
were minced in phosphate buffered saline (PBS) and digested in
Dulbeccos’ modified Eagle’s medium (DMEM) supplemented with
15% fetal bovine serum (FBS) (Hyclone), 1% penicillin-strepto-
mycin (Gibco), 0.32 mg/ml Collagenase IV (Sigma), and
2500 IU/ml DNase I for 6 h at 39uC. The cells were then
centrifuged at 1,000 rpm for 5 min, followed by suspension in
DMEM supplemented with 15% FBS, 0.5% penicillin-streptomy-
cin, 5% L-glutamine, 2.5% pyruvate, and 2.5 ng/ml basic
fibroblast growth factor. The cells were cultured in 10 cm dishes
for 12 h and then frozen in FBS containing 10% dimethyl
sulfoxide for future use.
Ear tissues from newborn piglets were treated with 75% ethanol
for 5 min and then washed thrice with PBS containing 1.5%
penicillin-streptomycin. The ear tissues were minced, and the
fibroblasts in the ear were isolated and cultured in the same
manner as described above.
PFFs transfection and selection
PFFs were thawed and cultured in 10 cm dishes until 90%
confluent. Then, 1610
6 PFFs in 800 ml PBS containing 25 mgo f
linearized pTGZC or pZCpTG were electroporated at 230 v/cm
and 500 mF using a Gene Pulse Xcell electroporator (Bio-Rad).
After 24 h of recovery, the electroporated cells were selected with
1 mg/ml G418 (Merck) for 10 days. Cell colonies co-expressing
the four fluorescent proteins were picked up and cultured in 48-
well plates. The cells were transferred to 35 cm dishes and
cultured for 3–4 days until confluent, and then the cells were
frozen for future use.
SCNT and transgenic pig generation
Oocytes were processed as previously described [5]. Pig ovaries
were purchased from a local slaughter house. Briefly, cumulus
oocyte complexes (COCs) were aspirated from antral follicles and
washed with maturation medium (Tissue Culture Medium 199)
(Gibco) supplemented with 0.1% (w/v) polyvinyl alcohol (Sigma),
3.05 mM D-glucose, 0.91 mM sodium pyruvate (Sigma), 0.57 nM
cysteine (Sigma), 0.5 mg/ml LH (Sigma), 0.5 mg /ml FSH (Sigma),
10 ng/ml epidermal growth factor (Sigma), 10% (v/v) porcine
follicular fluid, 75 mg /ml penicillin G, and 50 mg /ml streptomy-
cin. The COCs were then transferred to a four-well multidish
(Nunc) containing 500 ml of the maturation medium covered with
mineral oil and pre-equilibrated at 39uC overnight. After 42–44 h
of incubation, the oocytes were released from the COCs by
vigorous vortex for 4 min in TL-Hepes containing 0.1% polyvinyl
alcohol and 0.1% hyaluronidase (Sigma). The polar body and
associated metaphase plate of the oocytes were aspirated using
glass pipettes in micromanipulation medium supplemented with
7.5 mg/ml cytochalasin B. Denuded oocytes were used as the
recipients for SCNT.
The transgenic PFFs were thawed and grown to subconfluency
prior to SCNT. Cells with uniform co-expression of the four
fluorescent proteins were selected under fluorescent microscopy
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space of the oocytes. The oocyte-donor cell complexes were
activated to fuse and become reconstructed embryos with two
successive DC pulses at 1.2 kv/cm for 30 ms using an electrofusion
instrument (BLS). The reconstructed embryos were cultured in
embryo-development medium PZM3 at 39uC overnight and then
surgically transferred to recipient gilts exhibiting natural estrus.
The pregnancy status of the gilts was monitored weekly using an
ultrasound scanner beginning on Day 24 after the implantation.
All cloned piglets were delivered by natural birth. To monitor in
vitro development, transgenic and nontransgenic SCNT embryos
were cultured for 6 days until they reached the blastocyst stage.
Genotype identification
Genomic DNA was extracted from primary fibroblasts isolated
from newborn piglets using PureLink Genomic DNA Mini Kit
(Invitrogen). Two pairs of primers were designed to detect ZC and
TG fragments, with each primer located in the coding sequence of
each fluorescent gene. The ZC forward (59-CATGTAC-
CTGCTGCTGAAG-39) and reverse (59-CTGAAGCACTG-
CACGCCCCAG-39) primers yielded a 507 bp amplification
product. Given that tdTomato cDNA contains two tandem
repeated sequences and the TG forward primer is located in this
sequence, two products (1572 bp and 488 bp) were amplified with
the TG forward (59-GTGGAGTTCAAGACCATCTAC-39) and
reverse (59-CTGAAGCACTGCACGCCGT-39) primers. For
PCR, 0.1 mg of genomic DNA extract was added to 19 ml PCR
buffer containing 0.2 mM primers, 0.2 mM dNTPs, 50 U/ml of
ExTaq polymerase (TaKaRa). The pZCpTG vector DNA was
used as positive control, whereas the genomic DNA of wild-type
(WT) PFFs was used as negative control. The PCR products were
analyzed by 2% agarose gel electrophoresis.
Fluorescent protein expression analysis
Fibroblasts were seeded on coverslips for 24 h, fixed with 4%
paraformaldehyde for 5 min, washed with PBS, and mounted
onto slides for observation. One of the transgenic piglets was
sacrificed, and various tissues, including the liver, kidney, hoof,
heart, tongue, skin, nose, and lung, were fixed in 4% paraformal-
dehyde at 4uC overnight, washed thoroughly with PBS, and
cryosectioned at 20 mm thickness. The fibroblasts and tissue slices
were observed under a confocal microscope (Leica TCS SP2).
ZsYellow1, ECFP, tdTomato, and EGFP were excited at 514,
458, 543, and 488 nm, respectively. Fluorescence intensity was
measured using Leica Confocal Software.
The co-expression of the fluorescent proteins in the recon-
structed embryos was observed using a fluorescence microscope
(Olympus BX51) under appropriate excitation filters (490–500 nm
for ZsYellow1, 425–445 nm for ECFP, 535–555 nm for tdTo-
mato, and 460–480 nm for EGFP).
The fluorescent proteins expressed in the living transgenic
piglets were directly observed using goggles specifically designed
by Biological Laboratory Equipment Maintenance and Service
Ltd. for observing fluorescence in living organisms.
Real-time PCR
Total RNA was extracted from various tissues of transgenic
piglets using TRIzol Reagent (Invitrogen) and treated with DNase I
(TaKaRa) according to the provided instructions. First-strand
cDNA was synthesized using Superscript
TM III Reverse Transcrip-
tase (Invitrogen), and mRNA levels of target genes were determined
by real-time PCR. The real-time primers for ZsYellow1 were:
forward (59-CCCAGGACATCGTGGACTACTT-39) and reverse
(59-ACGCCGTTGAAGATGCTCTT-39), whereas those for
tdTomato were: forward (59-GCTGAAGGGCGAGATCCA-39)
and reverse (59- GTGGGAGGTGATGTCCAGCTT-39). Consid-
ering that only a few nucleotides are differed between the coding
sequences of EGFP and ECFP, we designed a primer pair that was
able to detect both EGFP and ECFP: forward (59-CATGCCC-
GAAGGCTACGT-39) and reverse (59- GCTTGTGCCCCAG-
GATGTT-39). 18S rRNA was used as the reference gene.
Statistical analysis
Data in this study were expressed as mean 6 S.D. of at least
three independent experiments. Statistical significance was
determined using the two-tailed Student’s t- test. p,0.05 was
considered statistically significant.
Results
Construction of vectors for the co-expression of four
fluorescent proteins
The pTGZC and pZCpTG vectors were constructed via
multiple steps of cloning as described in Methods, and their maps
Figure 1. Maps of the pTGZC (A) and pZCpTG (B) vectors.
doi:10.1371/journal.pone.0019986.g001
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polycistronic cassette TGZC, which was mediated by the 2A
peptide. The transcription of TGZC was driven by a single CAG
promoter. In contrast, the pZCpTG vector contained two CAG
promoters and two independent bicistronic cassettes: TG and ZC.
Each cassette has its own CAG promoter. The pTGZC and
pZCpTG vectors were transfected into 293T cells using
Lipofectamine 2000 (Invitrogen). The uniformly high co-expres-
sion levels of the four fluorescent proteins showed that both vectors
worked well in cell lines (data not shown).
Co-expression of the four fluorescent proteins in PFFs
and blastocysts
Ten days after G418 selection, 10 PFFs colonies transfected
with linearized pTGZC were randomly selected from each of the
eight 10 cm dishes to evaluate the co-expression of the four
fluorescent proteins in PFFs. Among the 80 selected colonies, 19
(23.75%) were found to co-express the four proteins and only 6
(7.5%) co-expressed all four proteins at uniformly high levels. In
the SCNT-blastocysts derived from the pTGZC PFFs, the
fluorescence intensities of the proteins encoded by the downstream
genes (ZsYellow1 and ECFP) were markedly lower than those of
the proteins encoded by the upstream genes (tdTomato and
EGFP) in the vector (data not shown). However, when the 2A-
based double-promoter vector pZCpTG was used, 54.3% (38/70)
of the colonies obtained from the seven dishes co-expressed the
proteins at uniformly high levels (Figure 2A). The blastocysts
derived from the pZCpTG PFFs also consistently co-expressed the
four fluorescent proteins (Figure 2B).
These results suggest that although the 2A peptide was highly
efficient in mediating polycistronic expression (pTGZC) in the cell
lines, it was not significantly efficient in the primary cells and
embryos, especially for the expression of the downstream genes.
However, when it was used solely for mediating a bicistronic
expression (pZCpTG), it was efficient in the primary cells and
embryos. Therefore, the 2A-based double-promoter vector
pZCpTG was used for the generation of the multi-transgenic pigs
in this study.
In vitro development of multi-transgenic embryos
The rate of embryonic development in vitro was compared
between transgenic SCNT (pZCpTG-PFF) and nontransgenic
SCNT (WT-PFF) embryos (Table 1). The overall developmental
rates of transgenic and nontransgenic SCNT embryos showed no
significant differences at both two-cell stage [(86.860.8)% vs.
(87.961.0)%] and blastocyst stage [(20.461.3)% vs (20.961.0)%],
suggesting that the transgenes had no significant impact on
embryonic development.
Generation of multi-transgenic pigs and genotype
identification
The pZCpTG PFFs co-expressing the four fluorescent proteins
were used as donor cells for SCNT to obtain multi-transgenic pigs.
A total of 840 reconstructed embryos were transferred to 7
recipient gilts. Early pregnancy was observed in 4 gilts, and 2 gilts
went to full term. Eleven live male piglets were born from the 2
gilts by natural delivery. These piglets appeared normal at birth
and were observed to have normal growth 8 months later.
Genomic DNA extracted from the ear fibroblasts of Piglets 2, 3,
4, 6, 7, 9 and 10 was used for PCR to confirm the presence of the
four fluorescent protein genes in the genome of the cloned piglets.
As shown in Figure 3, these piglets contained the four fluorescent
protein genes, confirming that they were multi-transgenic pigs.
Co-expression of the four fluorescent proteins in
fibroblasts isolated from multi-transgenic piglets
The fibroblasts isolated from the ear tissue of the newborn
piglets were observed under a confocal microscope, and the co-
expression of the four fluorescent proteins was observed in
fibroblasts from all of eleven piglets. The fibroblasts from most
multi-transgenic piglets, inclu d i n gP i g l e t2 ,3 ,4 ,5 ,7 ,1 0 ,a n d
Figure 2. Co-expression of the four fluorescent proteins in PFFs and blastocysts. (A) PFFs transfected with the linearized pZCpTG vector
were observed under a confocal microscope using appropriate filters. The scale bar represents 10 mm. (B) Several reconstructed embryos derived
from the pZCpTG PFFs were cultured until they reached the blastocyst stage. The blastocysts were observed under a fluorescence microscope using
appropriate filters.
doi:10.1371/journal.pone.0019986.g002
Table 1. Development ability of nuclear transfer embryos
derived from pZCpTG-PFFs and WT-PFFs.
Embryo type Cultured Cleaved (%) Blastocyst (%)
WT-PFF 235 206 (87.961.0) 47 (20.961.0)
pZCpTG-PFF 240 208 (86.860.8)* 43 (20.461.3)*
The embryo numbers are the total numbers counted from three independent
experiments, and the percentage values in the third and fourth columns are
shown as mean 6 S.D.
*p.0.05 compared with WT-PFF; no significant difference.
doi:10.1371/journal.pone.0019986.t001
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variations of protein expression were observed in the fibroblasts
from Piglet 1, 6, 8, and 9. As shown in Figure 4, the fluo-
rescence intensities of all proteins were identical in fibroblasts
from Piglet 10.
Co-expression of the four fluorescent proteins in various
tissues of a multi-transgenic piglet
Piglet 7 was sacrificed and the major tissues, including the liver,
kidney, hoof, heart, tongue, skin, nose, and lung, were collected for
expression analysis of the four fluorescent proteins. Different
fluorescent proteins exhibited rather consistent and uniform
expression in the same tissue (Figure 5), but the protein expression
levels in the different tissues slightly differed, possibly due to the
tissue specificity of the promoter and the protein synthesis activities
of the different tissues.
Real-time PCR was introduced to detect the mRNA levels of
the different proteins in the above tissues to confirm the uniform
co-expression of the four fluorescent proteins further. However,
considering that the coding sequences of EGFP and ECFP showed
extremely high similarity (99%), we could only design a pair of
primers that was able to detect both EGFP and ECFP. As shown
Figure 3. Genotype identification of multi-transgenic piglets. (A) Positions of the two primer pairs for genotype identification. Genomic DNA
from Piglet 2, 3, 4, 6, 7, 9, 10 was extracted, whereas ZC (B) and TG (C) bicistronic cassettes in the genome were detected by PCR using appropriate
primers. Lane 1, DNA marker; lane 2, positive control; lane 3, negative control; lane 4–10, genomic DNA from Piglet 2, 3, 4, 6, 7, 9 and 10.
doi:10.1371/journal.pone.0019986.g003
Figure 4. Co-expression of the four fluorescent proteins in the fibroblast isolated from multi-transgenic piglets. (A) Fibroblasts
isolated from the ear tissue of a representative animal (Piglet 10) observed under a confocal microscope using appropriate filters. The scale bar
represents 10 mm. (B) The fluorescence intensities of the four fluorescent proteins were measured. The results are shown as mean 6 S.D.
doi:10.1371/journal.pone.0019986.g004
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level were always approximately 2 folds of tdTomato and
ZsYellow1 mRNA level in the eight tissues. An especially high
mRNA expression was found in the heart tissue, whereas the
mRNA levels in other tissues were relatively close. This data
suggest that different fluorescent genes have consistent expression
in the same tissue, and the CAG promoter had an extremely high
activity in the heart.
Figure 5. Co-expression of the four fluorescent proteins in various tissues of a multi-transgenic piglet. Liver, kidney, hoof, heart,
tongue, skin, nose and lung tissues from Piglet 7 were cryosectioned and observed under a confocal microscope using appropriate filters. The scale
bar represents 100 mm.
doi:10.1371/journal.pone.0019986.g005
Generation of Multi-Transgenic Pigs by 2A Peptide
PLoS ONE | www.plosone.org 6 May 2011 | Volume 6 | Issue 5 | e19986Observation of fluorescence in living multi-transgenic
piglets
Fluorescent protein expression in living piglets was then
evaluated using goggles. With appropriate excitation and emission
filters, high levels of tdTomato, EGFP, and ECFP fluorescence
were observed in the nose, hoof, and tongue of the multi-
transgenic piglets, but not in the control piglet (Figure 7), further
supporting the high expression of fluorescent proteins in the
piglets. However, the instrument used was not sensitive enough to
discern yellow fluorescence, whose emission wavelength is
extremely close to that of EGFP. High ZsYellow1 expression in
multi-transgenic piglets has already been confirmed by confocal
microscopy observation and real-time PCR.
Discussion
Expanding applications of transgenic pigs, especially multi-
transgenic pigs, have been observed in agricultural and medical
research. Production of multi-transgenic pigs, however, remains to
be a great challenge. In this study we have underlined an effective
method for generating multi-transgenic pigs via a single round of
SCNT using the 2A peptide-based double-promoter vector
pTGpZC. All 11 piglets we obtained were multi-transgenic pigs,
with 7 piglets co-expressing the four fluorescent proteins at
equivalently high levels and 4 showing slight discrepancy in
protein expression.
Several studies on the generation of multi-transgenic pigs have
been previously reported. Zhou et al. [13] successfully produced
triple-transgenic pigs co-expressing human CD59, human mem-
brane cofactor protein (hMCP), and human decay-accelerating
factor (hDAF) by breeding among single-transgenic pigs. However,
different single-transgenic pigs should first be produced with their
method, which is time-consuming and costly. The combination of
all transgenes is not necessarily achieved if the single-transgenic
pigs are heterozygous. In addition, the prolonged period of sexual
maturity and gestation of pigs requires substantial time to generate
multi-transgenic pigs under this method.
SMGT, another technique in which sperms are pre-incubated
with multiple transgenes before insemination, has also been
optimized to produce multi-transgenic pigs [15]. Although this
method is of low cost, requires a short time to complete, and is
easy to use, the gene insertion is random, which might yield rather
different expression levels for different genes in the piglets [16]. In
addition, the sperms with all transgenes could not be intentionally
selected for artificial insermination, which results in the low
efficiency of multi-transgenic pig generation. The transgenes
introduced by SMGT have also been reported to be transiently
transmitted to the offspring at the early growth stage and be most
likely lost in adulthood [31].
Compared with the aforementioned strategies, our proposed
method has the following advantages: (1) It only requires a single
round of nuclear transfer and saves significant time and money. (2)
The four fluorescent genes are most likely to stay together and
exhibit a ‘‘one-expression, all-expression’’ pattern. (3) The
expression levels of the four fluorescent genes are consistent due
to their uniform conditions in the genome along with the two
CAG promoter-driven bicistronic cassettes and the high ‘‘cleav-
age’’ efficiency of 2A. This consistence in expression levels of the
2A upstream and downstream genes would probably be crucial to
the application of multi-transgenic pigs. (4) The donor cells for
SCNT are selected by G418, enabling to integration of the four
genes into the genome, resulting in a stable expression of
transgenes throughout the whole lifetime of transgenic pigs. (5)
Cells with a uniformly high co-expression of the four fluorescent
proteins could be selected directly under fluorescent microscopy
and used as donor cells for SCNT, which significantly increases
the efficiency of multi-transgenic pig production. (6) This method
could be easily applied to other functional genes. Three fluorescent
genes in our vector could be replaced with three functional genes,
with one fluorescent gene being retained as a marker for donor cell
selection prior to SCNT and protein expression in transgenic
piglets.
The 2A peptide-based single-promoter vector pTGZC, in
which the four fluorescent genes linked by 2A peptide were
driven by a single CAG promoter, was also constructed in this
study. However, it was not efficient enough to mediate the co-
expression of the four genes in the PFFs and embryos. The
expression of the last two genes was much weaker than that of the
first two genes in the polycistronic cassette, suggesting that the
‘‘cleavage’’ efficiencies at the downstream 2A sites were lower than
those at the upstream 2A sites. Thus, we chose the double-
promoter vector containing two 2A-mediated bicistronic cassettes
for multi-transgenic generation. Nevertheless, the mechanism for
the increased incomplete ‘‘cleavage’’ at the downstream 2A sites
remains to be elucidated.
The ‘‘cleavage’’ at a 2A site results in an upstream protein fused
with the 2A peptide without proline residue and a downstream
protein with a proline residue added to the N terminus. The
addition of a single proline to the N terminus of the second protein
should not significantly affect its function. However, whether the
addition of the 2A peptide to the first gene product does not
interfere with its intracellular localization and function in
transgenic pigs need to be verified. Most studies have shown that
the intracellular trafficking [19,29] and function [32,33] of the
transgene products are not affected by the 2A fusion, but
mistargetting [34] and functional abrogation [35] of transgene
products caused by such fusion have also been reported. Two
strategies may possibly address this problem in 2A-mediated multi-
transgenic production. First, the co-expression cassette could be
tested to ensure that all transgene products have normal
localizations and functions in donor cells before SCNT. The gene
that might be affected by 2A addition could be placed downstream
of the 2A site. Second, the furin cleavage site could be introduced
Figure 6. Expression profile analysis of four fluorescent
proteins in various tissues by RT-PCR. Total mRNA was extracted
from various tissues of Piglet 7. The mRNA levels of the target genes
(tdTomato, EGFP+ECFP and ZsYellow1) were determined by RT-PCR.
The results are shown as mean 6 S.D.
doi:10.1371/journal.pone.0019986.g006
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endogenous cellular proprotein convertase, could cleave at the
cleavage site sequence RXK/RR [37,38]. Therefore, placing a
furin cleavage site between the upstream gene and the 2A
sequence would eliminate all possible adverse effects caused by the
remaining 2A residues [36].
In this study, the mRNA levels of the four transgenes were
much higher in the heart than in other tissues due to the high
activity of the b-actin promoter-based CAG promoter in this
organ, which is rich in actin filaments [39]. The especially high
expression of transgenes driven by the CAG promoter has also
been observed in the mouse heart [40,41]. In the present work, the
CAG promoter was selected to construct a multi-transgenic pig
model. In other practical applications numerous promoters could
be used. For example, the liver-specific human apolipoprotein E
promoter could drive transgene expression in a liver-specific
pattern [42], which would be especially useful when the multi-
transgenic pigs are used as liver donors in xenotransplantation and
the transgene products are detrimental to other tissues in the pig.
In summary, multi-transgenic pigs uniformly co-expressing four
fluorescent proteins in various tissues were successfully produced
using a 2A peptide-based double-promoter vector through a single
round of SCNT. This study demonstrates that the 2A peptide
could be used to generate multi-transgenic pigs with high
efficiency, and provides a promising methodology to generate
multi-transgenic large animals.
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